Aurobindo Pharma Ltd
NSE:AUROPHARMA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 022.2
1 256
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
AUROPHARMA Price Targets Summary
Aurobindo Pharma Ltd
According to Wall Street analysts, the average 1-year price target for
AUROPHARMA
is 1 353.03 INR
with a low forecast of 1 020.1 INR and a high forecast of 1 722 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AUROPHARMA's stock price target?
Price Target
1 353.03
INR
According to Wall Street analysts, the average 1-year price target for
AUROPHARMA
is 1 353.03 INR
with a low forecast of 1 020.1 INR and a high forecast of 1 722 INR.
What is Aurobindo Pharma Ltd's Revenue forecast?
Projected CAGR
9%
For the last 13 years the
compound annual growth rate for
Aurobindo Pharma Ltd's revenue is
16%.
The projected
CAGR
for the next 3 years is
9%.
What is Aurobindo Pharma Ltd's Operating Income forecast?
Projected CAGR
9%
For the last 13 years the
compound annual growth rate for
Aurobindo Pharma Ltd's operating income is
21%.
The projected
CAGR
for the next 3 years is
9%.
What is Aurobindo Pharma Ltd's Net Income forecast?
Projected CAGR
13%
The
compound annual growth rate
of Aurobindo Pharma Ltd's net income for the next 3 years is
13%.
